Death from COVID-19 in a Fully Vaccinated Subject: A Complete Autopsy Report

A correctly implemented and widely accepted vaccination campaign was the only truly effective weapon to reduce mortality and hospitalizations related to COVID-19. However, it was not 100% effective and has not eliminated COVID-19. Even though more than 60% of the worldwide population is fully vaccinated (meaning that these subjects have completed the recommended vaccine cycle), subjects continue to die from COVID-19, particularly in the presence of comorbidities. In this scenario, autopsies play a crucial role in understanding the pathophysiological mechanisms of SARS-CoV-2 in vaccinated subjects and adapting therapies accordingly. This case report analyzes the death of a fully vaccinated patient who suffered from comorbidities and died from COVID-19; we provide a complete autopsy data set. On microscopic examination, the lungs showed massive interstitial pneumonia, areas of inflammation with interstitial lympho-plasma cell infiltrate, and interstitial edema. The liver showed granulocytes within the hepatic parenchyma. All these elements were consistent with previous published data on unvaccinated patients who had died from COVID-19. The present study is the first that analyzes, through a complete autopsy and a microscopic analysis of all organs, a death related to COVID-19 despite vaccine administration. In this regard, to the best of our knowledge, no other studies have been published reporting a complete autopsy. This study reports, on the one hand, the importance of vaccination programs in the fight against COVID-19, and, on the other hand, it hypothesizes that the vaccine does not offer complete immunity to SARS-CoV-2, particularly in elderly subjects with comorbidities.

[1]  D. Montefiori,et al.  A Bivalent Omicron-Containing Booster Vaccine against Covid-19 , 2022, The New England journal of medicine.

[2]  D. Barouch Covid-19 Vaccines — Immunity, Variants, Boosters , 2022, The New England journal of medicine.

[3]  Rahma Tsania Zhuhra,et al.  SARS-CoV-2 persistence and infectivity in COVID-19 corpses: a systematic review , 2022, Forensic Science, Medicine and Pathology.

[4]  A. Firenze,et al.  The Impact on Healthcare Workers of Italian Law n. 24/2017 “Gelli–Bianco” on Patient Safety and Medical Liability: A National Survey , 2022, International journal of environmental research and public health.

[5]  K. Khunti,et al.  Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study , 2022, The Lancet Diabetes & Endocrinology.

[6]  M. Horowitz The Vaccine-Hesitant Moment , 2022, The New England journal of medicine.

[7]  A. Wilder-Smith,et al.  Does the World Still Need New Covid-19 Vaccines? , 2022, The New England journal of medicine.

[8]  M. Salerno,et al.  Autopsies in COVID-related deaths: The need for following the model of German COVID-19 autopsy registry , 2022, The Lancet Regional Health - Europe.

[9]  R. Arbel,et al.  Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years , 2022, Nature Medicine.

[10]  S. Gharbia,et al.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.

[11]  R. Arbel,et al.  Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 , 2022, The New England journal of medicine.

[12]  J. Blay,et al.  Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients , 2022, European Journal of Cancer.

[13]  F. Sessa,et al.  The Impact of the COVID-19 Pandemic on the Practice of Forensic Medicine: An Overview , 2022, Healthcare.

[14]  C. Tripodo,et al.  Histological and immunohistochemical findings in a fatal case of thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. , 2022, Pathology, research and practice.

[15]  P. Mannucci,et al.  Vaccine-induced immune thrombotic thrombocytopenia with atypical vein thrombosis: Implications for clinical practice , 2022, Phlebology.

[16]  N. Andrews,et al.  Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England , 2022, Nature Medicine.

[17]  N. Andrews,et al.  Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines , 2022, The New England journal of medicine.

[18]  Savitri Sharma,et al.  Comorbidities and Vaccination Status of COVID-19 All-Cause Mortality at a Tertiary Care Center of Western India , 2022, Cureus.

[19]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[20]  A. Fauci,et al.  Universal Coronavirus Vaccines - An Urgent Need. , 2021, The New England journal of medicine.

[21]  K. Leung,et al.  Managing waning vaccine protection against SARS-CoV-2 variants , 2021, The Lancet.

[22]  G. Screaton,et al.  Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum , 2021, The Lancet.

[23]  D. Easton,et al.  Covid-19 Vaccine Effectiveness in New York State , 2021, The New England journal of medicine.

[24]  F. Sessa,et al.  Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review , 2021, Journal of clinical medicine.

[25]  F. Sessa,et al.  Do We Really Need Hazard Prevention at the Expense of Safeguarding Death Dignity in COVID-19? , 2021, Diagnostics.

[26]  C. Thomas,et al.  Postmortem investigation of fatalities following vaccination with COVID-19 vaccines , 2021, International Journal of Legal Medicine.

[27]  K. Khunti,et al.  Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study , 2021, BMJ.

[28]  Michael J. Ryan,et al.  Considerations in boosting COVID-19 vaccine immune responses , 2021, The Lancet.

[29]  C. Pérez,et al.  Influence of Health Beliefs on COVID-19 Vaccination among Individuals with Cancer and Other Comorbidities in Puerto Rico , 2021, Vaccines.

[30]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[31]  A. Stray‐Pedersen,et al.  Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series , 2021, Frontiers in Neurology.

[32]  R. Myers,et al.  Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant , 2021, The New England journal of medicine.

[33]  E. Undurraga,et al.  Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile , 2021, The New England journal of medicine.

[34]  M. Libra,et al.  Post-Mortem Detection of SARS-CoV-2 RNA in Long-Buried Lung Samples , 2021, Diagnostics.

[35]  Ross J. Harris,et al.  Effect of Vaccination on Household Transmission of SARS-CoV-2 in England , 2021, The New England journal of medicine.

[36]  C. Tripodo,et al.  COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis , 2021, Diagnostics.

[37]  C. Tripodo,et al.  Post-mortem findings in vaccine-induced thrombotic thrombocytopenia , 2021, Haematologica.

[38]  C. Robertson,et al.  Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study , 2021, BMJ.

[39]  B. Ondruschka,et al.  Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®) , 2021, Legal Medicine.

[40]  C. Röcken,et al.  First case of postmortem study in a patient vaccinated against SARS-CoV-2 , 2021, International Journal of Infectious Diseases.

[41]  M. Antonelli,et al.  Hospital-Acquired Infections in Critically Ill Patients With COVID-19 , 2021, Chest.

[42]  H. Kwok Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces , 2021, International journal of biological sciences.

[43]  V. Rapisarda,et al.  Safe Management Strategies in Clinical Forensic Autopsies of Confirmed COVID-19 Cases , 2021, Diagnostics.

[44]  M. Hernán,et al.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting , 2021, The New England journal of medicine.

[45]  S. Corrao,et al.  More than Pneumonia: Distinctive Features of SARS-Cov-2 Infection. From Autopsy Findings to Clinical Implications: A Systematic Review , 2020, Microorganisms.

[46]  R. Testi,et al.  Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression , 2020, Diagnostics.

[47]  G. Li Volti,et al.  The Post-Lockdown Era: What Is Next in Italy? , 2020, Frontiers in Pharmacology.

[48]  F. Sessa,et al.  Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review , 2020, Journal of clinical medicine.

[49]  R. Claus,et al.  Postmortem Examination of Patients With COVID-19. , 2020, JAMA.

[50]  F. Martinez,et al.  Severe Covid-19. , 2020, The New England journal of medicine.

[51]  Carlos Del Rio,et al.  Mild or Moderate Covid-19. , 2020, The New England journal of medicine.

[52]  U. Camenisch,et al.  Value of immunohistochemistry in the detection of BRAFV600E mutations in fine‐needle aspiration biopsies of papillary thyroid carcinoma , 2014, Cancer cytopathology.

[53]  R. Deshmukh,et al.  VEGF and CD 34: A correlation between tumor angiogenesis and microvessel density-an immunohistochemical study , 2013, Journal of oral and maxillofacial pathology : JOMFP.

[54]  Prakhar Kapoor,et al.  VEGF: A critical driver for angiogenesis and subsequent tumor growth: An IHC study , 2012, Journal of oral and maxillofacial pathology : JOMFP.

[55]  OUP accepted manuscript , 2022, Clinical Infectious Diseases.